GENEVA, March 17 -- UNIQURE BIOPHARMA B.V. (Paasheuvelweg 251105 BP Amsterdam) filed a patent application (PCT/EP2024/074730) for "NOVEL NEUROTROPIC RECOMBINANT ADENO-ASSOCIATED VIRUS PARTICLES" on Sep 04, 2024. With publication no. WO/2025/051805, the details related to the patent application was published on Mar 13, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ANGGAKUSUMA, - (c/o uniQure biopharma B.V.Paasheuvelweg 251105 BP Amsterdam), KIEPER, Sebastian Niklas (c/o uniQure biopharma B.V.Paasheuvelweg 251105 BP Amsterdam)
Abstract:
The present invention relates to the fields of medic...